# Chris Huang

> Chris Huang, also identified as Huang Hongwei, is the co-founder and CEO of Virogin Biotech. A Fudan-trained manager and CFA charterholder with a DBA from the University of Hong Kong, he previously held senior operating and board roles in the Sanjiu group. At Virogin, he is responsible for strategy and operations across a company with a Canada–China footprint.

- **Role:** Co-founder and Chief Executive Officer at Virogin Biotech
- **Organizations:** Virogin Biotech, Shenzhen Southern Pharmaceutical Factory, Shenzhen Jiuhui Industrial, Shenzhen Sanjiu Fine Chemical, Yichun Engineering Machinery, Sanjiu Yigong Biochemistry
- **Education:** Bachelor’s degree in Management, Fudan University, Master’s degree in Business Administration, Fudan University, Doctor of Business Administration, The University of Hong Kong
- **Known for:** Co-founded Virogin Biotech in 2015 with William Jia., Led Virogin as CEO during its US$62 million Series C, US$80 million Series D1 and US$127 million Series D2 financing announcements in 2020–2021., Obtained the CFA qualification in September 2012.

## Career timeline

- **1987** — Entered Fudan University to study management.
- **1991** — Graduated from Fudan; began working at Shenzhen Southern Pharmaceutical Factory, where he managed the Supply Department through 1993.
- **1993–1996** — Deputy general manager of Shenzhen Jiuhui Industrial.
- **1996–1999** — Deputy general manager and then general manager of Shenzhen Sanjiu Fine Chemical.
- **1998–2000** — Concurrently held director, deputy general manager and board secretary roles at Yichun Engineering Machinery.
- **1999** — Awarded an MBA by Fudan University.
- **2000–2008** — Held director, deputy general manager, board secretary and general manager roles at Sanjiu Yigong Biochemistry.
- **2012** — Obtained the CFA qualification in September.
- **2014** — Returned to China to work in venture investment, according to a 2018 career account.
- **2015** — Co-founded Virogin with William Jia; CEO since June 2015.
- **2019** — Virogin announced an agreement to form a joint venture with China National Biotec Group.
- **2020** — Virogin completed a US$62 million Series C in September.
- **2021** — Virogin announced US$80 million Series D1 and US$127 million Series D2 financing rounds.
- **2022** — Awarded a DBA by the University of Hong Kong.

## Achievements

- Co-founded Virogin Biotech in 2015 with William Jia.
- Led Virogin as CEO during its US$62 million Series C, US$80 million Series D1 and US$127 million Series D2 financing announcements in 2020–2021.
- Obtained the CFA qualification in September 2012.
- Awarded a Doctor of Business Administration by the University of Hong Kong in 2022.

## Latest updates

- **2024-06** — SAP published an account quoting Huang on an eight-month ERP cloud rollout going live in China and Canada.

## Links

- Website: https://virogin.com/
- LinkedIn: https://www.linkedin.com/in/chris-huang-24a2a853/

---

Profile page: https://yespress.io/chris-huang
Published by YesPress — https://yespress.io
Last updated: 2026-10-25